Skip to main content
. Author manuscript; available in PMC: 2010 Mar 11.
Published in final edited form as: Structure. 2009 Mar 11;17(3):363–373. doi: 10.1016/j.str.2009.01.006

Figure 4.

Figure 4

TFIID immunolabeling with Taf2 antibody

(A) Immunolabeling of TFIID by an antibody directed against the N-terminus of Taf2p. The 3-D model of TFIID is represented in yellow and the red surface represents the difference map between the antibody-labeled TFIID and the unlabeled complex. (B) Alignment between Leukotriene A4 hydrolase and human Taf2p. The conserved amino acids are highlighted. (C) Docking of the atomic structure of the leukotriene A4 hydrolase domain that is homologous to the N-terminal part of Taf2p into the additional density present in lobe C2 of model 4 shown in teal. The bars represent 2 nm; indicated in red is the additional density of the anti-Taf2p IgG.